Search

Shin Lin Chen

Examiner (ID: 17983, Phone: (571)272-0726 , Office: P/1632 )

Most Active Art Unit
1632
Art Unit(s)
1633, 1632
Total Applications
1467
Issued Applications
727
Pending Applications
150
Abandoned Applications
592

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 6089365 [patent_doc_number] => 20110217779 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-08 [patent_title] => 'Compositions and Methods for Non-Targeted Activation of Endogenous Genes' [patent_app_type] => utility [patent_app_number] => 13/037742 [patent_app_country] => US [patent_app_date] => 2011-03-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 62 [patent_figures_cnt] => 62 [patent_no_of_words] => 50350 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0217/20110217779.pdf [firstpage_image] =>[orig_patent_app_number] => 13037742 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/037742
Compositions and Methods for Non-Targeted Activation of Endogenous Genes Feb 28, 2011 Abandoned
Array ( [id] => 7766103 [patent_doc_number] => 20120034191 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-02-09 [patent_title] => 'EXTRACELLULAR MATRIX COMPOSITIONS FOR TISSUE REGENERATION' [patent_app_type] => utility [patent_app_number] => 13/033053 [patent_app_country] => US [patent_app_date] => 2011-02-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4541 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0034/20120034191.pdf [firstpage_image] =>[orig_patent_app_number] => 13033053 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/033053
EXTRACELLULAR MATRIX COMPOSITIONS FOR TISSUE REGENERATION Feb 22, 2011 Abandoned
Array ( [id] => 7669038 [patent_doc_number] => 20110318307 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-29 [patent_title] => 'XIAP THERAPY' [patent_app_type] => utility [patent_app_number] => 13/033283 [patent_app_country] => US [patent_app_date] => 2011-02-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 16566 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13033283 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/033283
XIAP THERAPY Feb 22, 2011 Abandoned
Array ( [id] => 7734597 [patent_doc_number] => 20120016491 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-01-19 [patent_title] => 'LAMINATE SHEET ARTICLES FOR TISSUE REGENERATION' [patent_app_type] => utility [patent_app_number] => 13/033102 [patent_app_country] => US [patent_app_date] => 2011-02-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 3756 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0016/20120016491.pdf [firstpage_image] =>[orig_patent_app_number] => 13033102 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/033102
Laminate sheet articles for tissue regeneration Feb 22, 2011 Issued
Array ( [id] => 8720148 [patent_doc_number] => 20130071365 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-03-21 [patent_title] => 'INDUCED HEPATOCYTES' [patent_app_type] => utility [patent_app_number] => 13/579038 [patent_app_country] => US [patent_app_date] => 2011-02-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 7593 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13579038 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/579038
INDUCED HEPATOCYTES Feb 15, 2011 Abandoned
Array ( [id] => 9496552 [patent_doc_number] => 08735365 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-05-27 [patent_title] => 'Targeting PAX2 for the induction of DEFB1-mediated tumor immunity and cancer therapy' [patent_app_type] => utility [patent_app_number] => 13/005579 [patent_app_country] => US [patent_app_date] => 2011-01-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 71 [patent_figures_cnt] => 26 [patent_no_of_words] => 31394 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 78 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13005579 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/005579
Targeting PAX2 for the induction of DEFB1-mediated tumor immunity and cancer therapy Jan 12, 2011 Issued
Array ( [id] => 10032915 [patent_doc_number] => 09074223 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-07-07 [patent_title] => 'Vectors and methods for transducing B cells' [patent_app_type] => utility [patent_app_number] => 13/520921 [patent_app_country] => US [patent_app_date] => 2011-01-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 15794 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 191 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13520921 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/520921
Vectors and methods for transducing B cells Jan 6, 2011 Issued
Array ( [id] => 6189775 [patent_doc_number] => 20110172144 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-07-14 [patent_title] => 'METHODS FOR INCREASING EXPRESSION OF SERCA2A IN CARDIAC MUSCLE' [patent_app_type] => utility [patent_app_number] => 12/984552 [patent_app_country] => US [patent_app_date] => 2011-01-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11002 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0172/20110172144.pdf [firstpage_image] =>[orig_patent_app_number] => 12984552 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/984552
METHODS FOR INCREASING EXPRESSION OF SERCA2A IN CARDIAC MUSCLE Jan 3, 2011 Abandoned
Array ( [id] => 7560837 [patent_doc_number] => 20110274669 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-11-10 [patent_title] => 'THERAPEUTIC RETROVIRAL VECTORS FOR GENE THERAPY' [patent_app_type] => utility [patent_app_number] => 12/976078 [patent_app_country] => US [patent_app_date] => 2010-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 17521 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0274/20110274669.pdf [firstpage_image] =>[orig_patent_app_number] => 12976078 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/976078
THERAPEUTIC RETROVIRAL VECTORS FOR GENE THERAPY Dec 21, 2010 Abandoned
Array ( [id] => 6040914 [patent_doc_number] => 20110093963 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-04-21 [patent_title] => 'Enhanced Expression of Human or Humanized Immunoglobulin in Non-Human Transgenic Animals' [patent_app_type] => utility [patent_app_number] => 12/972290 [patent_app_country] => US [patent_app_date] => 2010-12-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 10778 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0093/20110093963.pdf [firstpage_image] =>[orig_patent_app_number] => 12972290 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/972290
Enhanced expression of human or humanized immunoglobulin in non-human transgenic animals Dec 16, 2010 Issued
Array ( [id] => 8066057 [patent_doc_number] => 20110243995 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-06 [patent_title] => 'Method for Rational Mutagenesis of Alpha/Beta T-Cell Receptors and Correspondingly Mutated MDM2-Protein Specific Alpha/Beta T-Cell Receptors' [patent_app_type] => utility [patent_app_number] => 12/952259 [patent_app_country] => US [patent_app_date] => 2010-11-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 15454 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0243/20110243995.pdf [firstpage_image] =>[orig_patent_app_number] => 12952259 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/952259
Method for rational mutagenesis of α/βT-cell receptors and correspondingly mutated MDM2-protein specific α/βT-cell receptors Nov 22, 2010 Issued
Array ( [id] => 6009082 [patent_doc_number] => 20110061114 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-10 [patent_title] => 'NOVEL PRO258 GENE DISRUPTIONS, AND METHODS RELATING THERETO' [patent_app_type] => utility [patent_app_number] => 12/945589 [patent_app_country] => US [patent_app_date] => 2010-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 74 [patent_figures_cnt] => 74 [patent_no_of_words] => 172133 [patent_no_of_claims] => 73 [patent_no_of_ind_claims] => 27 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0061/20110061114.pdf [firstpage_image] =>[orig_patent_app_number] => 12945589 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/945589
NOVEL PRO258 GENE DISRUPTIONS, AND METHODS RELATING THERETO Nov 11, 2010 Abandoned
12/925886 Lung cancer therapy using an engineered respiratory syncytial virus Nov 1, 2010 Abandoned
Array ( [id] => 8477130 [patent_doc_number] => 20120276537 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-11-01 [patent_title] => 'HOMOLOGOUS RECOMBINATION IN THE OOCYTE' [patent_app_type] => utility [patent_app_number] => 13/504587 [patent_app_country] => US [patent_app_date] => 2010-10-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 14639 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13504587 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/504587
HOMOLOGOUS RECOMBINATION IN THE OOCYTE Oct 27, 2010 Abandoned
Array ( [id] => 6189722 [patent_doc_number] => 20110172121 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-07-14 [patent_title] => 'ALLOGENEIC STEM CELL BANK' [patent_app_type] => utility [patent_app_number] => 12/908143 [patent_app_country] => US [patent_app_date] => 2010-10-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 6472 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0172/20110172121.pdf [firstpage_image] =>[orig_patent_app_number] => 12908143 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/908143
ALLOGENEIC STEM CELL BANK Oct 19, 2010 Abandoned
Array ( [id] => 8749325 [patent_doc_number] => 08415155 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-04-09 [patent_title] => 'Cardiomyocyte production' [patent_app_type] => utility [patent_app_number] => 12/907714 [patent_app_country] => US [patent_app_date] => 2010-10-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 37 [patent_figures_cnt] => 75 [patent_no_of_words] => 28360 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 177 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12907714 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/907714
Cardiomyocyte production Oct 18, 2010 Issued
Array ( [id] => 8441923 [patent_doc_number] => 20120258539 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-10-11 [patent_title] => 'USE OF NIBP POLYPEPTIDES' [patent_app_type] => utility [patent_app_number] => 13/499932 [patent_app_country] => US [patent_app_date] => 2010-10-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 9967 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13499932 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/499932
USE OF NIBP POLYPEPTIDES Oct 11, 2010 Abandoned
Array ( [id] => 8875589 [patent_doc_number] => 08470552 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-06-25 [patent_title] => 'Strategy to reduce lactic acid production and control PH in animal cell culture' [patent_app_type] => utility [patent_app_number] => 12/903046 [patent_app_country] => US [patent_app_date] => 2010-10-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 10235 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 101 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12903046 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/903046
Strategy to reduce lactic acid production and control PH in animal cell culture Oct 11, 2010 Issued
Array ( [id] => 6165840 [patent_doc_number] => 20110195505 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-08-11 [patent_title] => 'BACTERIAL STRAINS FOR BUTANOL PRODUCTION' [patent_app_type] => utility [patent_app_number] => 12/899760 [patent_app_country] => US [patent_app_date] => 2010-10-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 22558 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0195/20110195505.pdf [firstpage_image] =>[orig_patent_app_number] => 12899760 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/899760
BACTERIAL STRAINS FOR BUTANOL PRODUCTION Oct 6, 2010 Abandoned
Array ( [id] => 8979294 [patent_doc_number] => 20130212724 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-08-15 [patent_title] => 'Composition for Regenerating Hair Follicles Comprising CD36-Expressing Dermal Sheath Cells' [patent_app_type] => utility [patent_app_number] => 13/876608 [patent_app_country] => US [patent_app_date] => 2010-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 6556 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13876608 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/876608
Composition for Regenerating Hair Follicles Comprising CD36-Expressing Dermal Sheath Cells Sep 28, 2010 Abandoned
Menu